163 related articles for article (PubMed ID: 9364141)
1. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.
Victor TC; Warren R; Butt JL; Jordaan AM; Felix JV; Venter A; Sirgel FA; Schaaf HS; Donald PR; Richardson M; Cynamon MH; Van Helden PD
J Med Microbiol; 1997 Oct; 46(10):847-57. PubMed ID: 9364141
[TBL] [Abstract][Full Text] [Related]
2. Rifampicin resistance in Mycobacterium tuberculosis--rapid detection and implications in chemotherapy.
Pretorius GS; Sirgel FA; Schaaf HS; van Helden PD; Victor TC
S Afr Med J; 1996 Jan; 86(1):50-5. PubMed ID: 8685782
[TBL] [Abstract][Full Text] [Related]
3. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
Bifani PJ; Plikaytis BB; Kapur V; Stockbauer K; Pan X; Lutfey ML; Moghazeh SL; Eisner W; Daniel TM; Kaplan MH; Crawford JT; Musser JM; Kreiswirth BN
JAMA; 1996 Feb; 275(6):452-7. PubMed ID: 8627966
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
5. [Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis].
Wu X; Zhuang Y; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):332-5. PubMed ID: 10374440
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
Mathuria JP; Nath G; Samaria JK; Anupurba S
Infect Genet Evol; 2009 Dec; 9(6):1352-5. PubMed ID: 19786122
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
[TBL] [Abstract][Full Text] [Related]
8. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
10. Detection of multidrug resistance in Mycobacterium tuberculosis.
Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
[TBL] [Abstract][Full Text] [Related]
11. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain.
Torres MJ; Criado A; Gónzalez N; Palomares JC; Aznar J
Int J Tuberc Lung Dis; 2002 Feb; 6(2):160-3. PubMed ID: 11931416
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.
Höfling CC; Pavan EM; Giampaglia CM; Ferrazoli L; Aily DC; de Albuquerque DM; Ramos MC
Int J Tuberc Lung Dis; 2005 Jan; 9(1):87-93. PubMed ID: 15675556
[TBL] [Abstract][Full Text] [Related]
13. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
14. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
15. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
17. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
18. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients.
Zaker Bostanabad S; Titov LP; Slizen VV; Taghikhani M; Bahrmand A
Tuberk Toraks; 2007; 55(3):231-7. PubMed ID: 17978919
[TBL] [Abstract][Full Text] [Related]
19. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
20. [Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance].
Ohno H; Koga H; Kohno S
Kekkaku; 1998 Nov; 73(11):657-63. PubMed ID: 9866928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
